News Rebiotix microbiome drug success against C diff infection Patients suffering from a recurrent C diff infection have benefited from Rebiotix's microbiome treatment.
News UK spin-out Microbiotica wants to be world leader in microbi... Spin-out will exploit Sanger Institute expertise
News Novartis and J&J part of new US microbiome initiative The White House has launched a new national initiative focused on researching the microbiome with input from Novartis, Johnson & Johnson and others.
News J&J's oral IL-23 drug backed for psoriasis in EU J&J's oral psoriasis drug Icotyde heads up the list of new therapies recommended for EU approval at the CHMP's July meeting.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
